Plasmonic Nanoparticles for Targeted Skin Ablation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current laser treatments for skin conditions like acne are insufficiently effective, causing off-target side effects such as sensitivity, inflammation, and scarring due to the inability to selectively ablate specific cells in the dermis and epidermis without damaging surrounding tissues.

Innovation Solution

The use of plasmonic nanoparticles that generate surface plasmons in response to NIR radiation, which are delivered to specific skin structures like hair follicles and sebaceous glands, allowing for targeted thermal ablation using a composition comprising these nanoparticles and a cosmetically acceptable carrier, activated by energy sources like lasers or ultrasound.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If high intensity light energy (50-150 J/cm2) is used to damage sebaceous gland structures, then treatment effectiveness is improved, but off-target side effects worsen (light sensitivity, pain, inflammation, hyper/hypo-pigmentation, permanent scarring)

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidoff-target side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by functionalizing nanoparticles with specific ligands (transferrin, folate, biotin, peptides, antibodies) that bind selectively to target cells such as sebaceous glands, hair follicles, and sweat glands. This enables the treatment to affect only the intended target structures while leaving surrounding healthy tissues unaffected, thereby maintaining high treatment effectiveness while eliminating off-target side effects

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent uses nanoparticles as intermediary carriers that deliver the therapeutic effect locally. These nanoparticles are functionalized with target-specific ligands and loaded with therapeutic agents (genes, drugs, siRNA). The nanoparticles act as mediators between the external treatment and the target cells, enabling precise delivery of therapeutic payloads to specific skin structures without affecting surrounding tissues

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If most light wavelengths are used for treatment, then treatment coverage is improved, but skin penetration capability worsens (skin acts as filter preventing transmission)

Engineering Contradiction:
Improvetreatment coverageVSAvoidskin penetration capability
Core Design Contradiction:
Adaptability or versatilityVSSpeed

Solution Approach 1:

The patent utilizes near-infrared (NIR) light wavelengths (700-2500 nm) which have optimal penetration depth through skin tissue. By changing the wavelength parameter from visible/UV ranges to NIR range, the treatment achieves both deep skin penetration and versatility in treating various skin conditions at different depths including dermal and subcutaneous structures

Inventive Principle:
Principle #35Parameter changes

3Reliability

If UV/blue light is used for acne treatment, then anti-inflammatory effects are improved, but transdermal porphyrin penetration leads to off-target side effects

Engineering Contradiction:
Improveanti-inflammatory effectsVSAvoidlight sensitivity, pain, inflammation, hyper/hypo-pigmentation, permanent scarring
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses nanoparticles functionalized with target-specific ligands as intermediaries to deliver therapeutic payloads selectively to sebaceous glands and other skin structures. This targeted delivery mechanism replaces the non-specific UV/blue light approach, maintaining anti-inflammatory effects through localized therapy while eliminating the need for transdermal porphyrin penetration that causes off-target side effects

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent achieves local quality by functionalizing nanoparticles with ligands that specifically bind to target cells (transferrin for iron uptake pathways, folate for folate receptor expression, biotin for biotin receptor binding, peptides for specific cell surface receptors, antibodies for antigen-specific binding). This ensures the therapeutic effect is concentrated exactly where needed in the skin structures, maintaining efficacy while avoiding damage to surrounding healthy tissues

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables precise thermal ablation of target cells, reducing the risk of damage to surrounding tissues and improving treatment outcomes for skin conditions like acne by utilizing nanoparticles that absorb light and generate heat only in the desired areas.

Implementation Method 1

plasmonic nanoparticles that generate surface plasmons in response to NIR radiation

Methodology Applied
Scientific EffectSurface plasmon resonance:

Implementation Method 2

utilizing nanoparticles that absorb light and generate heat only in the desired areas

Methodology Applied
Scientific EffectLight absorption: Absorption (EM radiation)

Implementation Method 3

targeted thermal ablation of target cells for treating certain skin conditions

Methodology Applied
Scientific EffectThermal ablation: Ablation

Implementation Method 4

generate heat only in the desired areas

Methodology Applied
Scientific EffectHeat generation: Heating

Data Source

PatentUS20180325594A1Methods of treating skin conditions using plasmonic nanoparticles
Publication Date: 2018.11.15 SEBACIA INC

AI summary

Methods, and materials useful in such methods, of treating certain skin conditions are described. In brief, the methods impregnate portions of the skin needing treatment with plasmonic materials. Thereafter, surface plasmons are generated on the surface of these plasmonic materials by irradiating the treated skin with near infrared light that is absorbed by the plasmonic materials in the skin.